Navigation Links
NCH partners with Silicon Valley to market high-end diagnostic and medical research software
Date:10/30/2012

The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.

Nationwide Children's Hospital in Columbus, Ohio, and Transformatix Technologies, Inc., in Davis, California, have partnered to create BioLinQ, a new biomedical informatics company designed to supply advanced software solutions for disease diagnosis and medical research.

"Years of development at Nationwide Children's Hospital funded in part by the National Institutes of Health have laid the foundation for very mature, high-end solutions in digital pathology, biospecimen analysis and biorepository management," says Ken Murray, founder and CEO, Transformatix Technologies, Inc. "With the growth of molecular technology and the advent of personalized medicine, BioLinQ is poised to have a significant impact upon the diagnostic and research capabilities in hospitals, academic research centers and the pharmaceutical industry."

The vision of the late Stephen J. Qualman, MD, who developed the Biopathology Center at Nationwide Children's, provided the foundation to advance the hospital's capabilities in the field of pathology, as well as biobanking and sophisticated digital analysis. Software solutions developed at Nationwide Children's answer the needs for highly defined biospecimen analysis, workflow management, long-distance collaboration and efficient management of laboratory and biorepository functions.

"We are seeing, with the implementation of our software, the optimization of the scientific review process for translational research. The solutions also provide visualization into the multiple dynamics of clinical trial data to aid in clinical study design," explains Dave Billiter, director, Informatics, The Research Institute at Nationwide Children's Hospital. "For example, we have a cancer consortium which called for patients to receive rapid review in order to qualify for a specific trial. Because we had this powerful suite of software, we were able to quickly accommodate the consortium and more importantly enroll the patients in the study."

Functionalities encompassed in the BioLinQ suite of solutions include:

  • A web-based software solution combining the operation and pathology workflow functionality with a backend database to manage and support the use of digital pathology and virtual microscopy. This solution provides workflow management, image viewer, and image file format conversion capabilities using an advanced imaging framework.
  • A high-end web-based software solution supporting the data chain of custody from acquisition of a consented patient sample to the testing laboratory and through complex analysis. This solution was built with advanced programmatic techniques, with an easy-to-use data storing, organizing, and manipulating program. It combines disparate data sources throughout a research study in a scalable, structured fashion, regardless of an investigator's physical location. The solution also provides a scientific dashboard and interactive query.
  • A web-based solution supporting laboratory information management activities. It provides the functional best practices in managing a biorepository, whether the repository is advanced or early-stage. This solution provides the capabilities to track a specimen throughout its repository chain of custody with full reporting and audit trail functionality.


'/>"/>

Contact: Erin Pope
Erin.Pope@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Related biology news :

1. Immune system fighters speak in patterns of proteins, prefer squishy partners
2. British Ecological Society partners with Wiley open access journal Ecology and Evolution
3. DARPA director: Revolutionary weapons require strong S&T partnerships
4. Partnership enhances biology teaching at California community colleges
5. ShanghaiBio Corporation Partners with Ingenuity Systems to Address Challenges in Analysis and Interpretation of Genomics Data
6. MU celebrates $5 million partnership for advancing biomedical discoveries
7. BGI partners with the University of Birmingham
8. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
9. F1000 Research partners with figshare to provide smart ways of accessing data
10. Royal Astronomical Society and Oxford University Press partnership announced
11. Grants add to Northwestern-Qatar partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... Focus is on the ... to the scientifically intensive operations of companies in ... and industrial. In today,s pre-market research, Stock-Callers.com dedicates attention ... PTLA), OvaScience Inc. (NASDAQ: OVAS), Ocera Therapeutics Inc. ... OCUL ). Learn more about these stocks ...
(Date:3/27/2017)... , March 27, 2017 Roka Bioscience, Inc. ... testing solutions for the detection of foodborne pathogens,  today announced ... Sidoti & Company Spring 2017 Convention on March 29 at ... York Marriott Marquis. About Roka Bioscience ... Roka ...
(Date:3/27/2017)... ROCKVILLE, Md. , March 27, 2017 /PRNewswire/ ... $108.5 billion for 2016, according to a new ... patients, medical lab testing is performed to evaluate ... determine individual therapy, among other reasons.  The healthcare ... Services Market , provides an overview of ...
(Date:3/27/2017)... 27, 2017  Trovagene, Inc. (NASDAQ: TROV), a precision ... Officer, Bill Welch , will be presenting at ... 9:00 AM EDT at the Essex House in ... Chief Scientific Officer, Mark Erlander , Ph.D., will ... conference.   The presentation will be webcast live ...
Breaking Biology Technology: